Androstenedione Is the Preferred Androgen Source in Hormone Refractory Prostate Cancer--Letter

Title
Androstenedione Is the Preferred Androgen Source in Hormone Refractory Prostate Cancer--Letter
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 20, Issue 18, Pages 4971-4971
Publisher
American Association for Cancer Research (AACR)
Online
2014-09-15
DOI
10.1158/1078-0432.ccr-14-1123

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started